Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / July / From Peak Performance to Precision Healthcare
Omics Omics Proteomics Metabolomics & Lipidomics

From Peak Performance to Precision Healthcare

Travis Nemkov and Angelo D’Alessandro discuss how molecular profiling in elite athletes could inform personalized exercise, healthy aging, and cancer recovery

By James Strachan 07/13/2026 10 min read
  • Full Article
  • Summary
  • Listen
  • Report
  • Quiz
  • Top Institutions

Share

Objective:

To explore how analytical technologies can enhance the understanding of human physiology through the study of elite athletes under extreme physiological stress.

Approach:
  • Research Background: The program began in 2015, focusing on applying mass spectrometry and omics to sports science, transitioning from studying disease to optimal human health.
  • Sample Collection and Analysis: Utilized microsampling techniques to collect blood samples from elite cyclists and ultra-endurance runners, analyzing metabolic signatures linked to performance.
  • Performance Insights: Identified differences in metabolic pathways among elite athletes, particularly in fat-burning capacity and recovery between competitive stages.
  • Ultra-Endurance Studies: Investigated the physiological responses of ultra-endurance runners, revealing significant inflammatory responses and red blood cell turnover.
  • Application to Health: Aimed to apply findings to personalize exercise prescriptions for cancer survivors and improve understanding of healthy aging.
Key Findings:
  • Molecular signatures can distinguish between varying levels of athletic performance.
  • Top-performing cyclists maintain fat-burning capacity despite fatigue.
  • Ultra-endurance events induce significant inflammatory responses and red blood cell damage.
  • Metabolomic profiling may help tailor exercise interventions for cancer survivors.
Interpretation:

The research uses elite athletes as a model to understand optimal human physiology and the effects of extreme physical stress.

Limitations:
  • Initial focus on endurance sports may limit broader applicability.
  • Findings may not directly translate to non-athletic populations.
Conclusion:

The ultimate goal is to leverage insights from elite sports to inform precision healthcare strategies, particularly in exercise oncology.

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

James Strachan

Over the course of my Biomedical Sciences degree it dawned on me that my goal of becoming a scientist didn’t quite mesh with my lack of affinity for lab work. Thinking on my decision to pursue biology rather than English at age 15 – despite an aptitude for the latter – I realized that science writing was a way to combine what I loved with what I was good at. From there I set out to gather as much freelancing experience as I could, spending 2 years developing scientific content for International Innovation, before completing an MSc in Science Communication. After gaining invaluable experience in supporting the communications efforts of CERN and IN-PART, I joined Texere – where I am focused on producing consistently engaging, cutting-edge and innovative content for our specialist audiences around the world.

More Articles by James Strachan

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.